Bloomios

Bloomios Cash Flow per Share

The Operating Cash Flow per Share of Bloomios (BLMS) as of Oct 24, 2026 is -0.28 USD. In the previous year, Operating Cash Flow per Share was -0.44 USD — a change of -36.94% (higher).

Cash Flow per Share

-0.28USD

YoY

-36.94%

Last updated:

Operating Cash Flow per Share of Bloomios is 2023 -0.28 USD. Operating Cash Flow per Share of Bloomios was 2022 -0.44 USD. It decreases by -36.94% higher compared to the previous year.

The Bloomios Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
0.07 USD
Jan 1, 2021
-0.01 USD
Jan 1, 2022
-0.44 USD
Jan 1, 2023
-0.28 USD
The Bloomios Cash Flow per Share history
YEARCash Flow per ShareYoY
-0.28USD-36.94%
-0.44USD+5,623.06%
-0.01USD-111.82%
0.07USD-4,968.80%
-0.00USD+68.63%
-0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomios Stock analysis

What does Bloomios do? Bloomios, Inc. generates revenue through the wholesale distribution of U.S. hemp-derived supplements and cosmetic products. The company manufactures and distributes hemp-infused edibles, pet edibles, tinctures, shots, topicals, smokable hemp, and other products across seven categories including edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. BPL, a subsidiary of Bloomios, focuses on manufacturing and distributing hemp-derived nootropic and nutraceutical products to wholesalers and retailers. Bloomios provides private-label and white-label services with over 80 customizable products and custom formulation and manufacturing support for its customers. The company's primary customers are wholesalers and retailers who purchase its hemp-derived products for resale. Bloomios offers a comprehensive suite of services including custom formulation, order fulfillment, and brand development to support its clients. Its product portfolio spans multiple categories such as human edibles, pet edibles, liquid consumables, topicals, and smokable hemp, catering to both consumer and pet markets. Bloomios leverages its subsidiary BPL to expand its product offerings in the hemp-derived nootropic and nutraceutical sectors. The company's focus on customizable solutions allows it to serve a diverse range of clients seeking private-label and white-label hemp products. Through its wholesale distribution channels, Bloomios targets businesses looking to sell hemp-based supplements and cosmetics under their own brand names. Bloomios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomios stock

Operating Cash Flow per Share of Bloomios is -0.28 USD in 2023.

Operating Cash Flow per Share of Bloomios changed from -0.44 USD to -0.28 USD, representing a -36.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Bloomios since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bloomios

All Key Metrics — Bloomios